Pangea Biomed

📍 Tel Aviv, Israel🗓 Founded 2018👥 24 employees💰 Last funded Jun 2021
Biotechnology Research🌐 pangeabiomed.com
Website LinkedIn
Pangea is redefining precision oncology and increasing the number of patients who can benefit from it. Immunotherapy and precision oncology have been around for decades, providing hope for those with cancer, but less than 10 percent of cancer patients benefit from today’s treatments. By coupling the hidden power of RNA sequencing with ML-enabled network effects, our ENLIGHT platform can surface relevant biological insights to pinpoint the best path forward toward combating a patient’s cancer.
2
Total investors
1
Early stage
1
Mid stage
0
Late stage
2018
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
United States
1
United Kingdom
1
Frequently asked questions
Who invested in Pangea Biomed?
Pangea Biomed has 2 investors on record on gritt.io, including 1 early-stage backers, 1 mid-stage.
When did Pangea Biomed last raise funding?
The most recent investment in Pangea Biomed recorded on gritt.io was in June 2021.
When was Pangea Biomed founded?
Pangea Biomed was founded in 2018.
What industry is Pangea Biomed in?
Pangea Biomed operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Pangea Biomed based?
Pangea Biomed is headquartered in Tel Aviv, Israel.